SS Innovations International Inc. (NASDAQ: SSII) is positioning itself as a key player in the rapidly growing robotic surgery market by focusing on affordability, physician training, and international expansion. The company's proprietary SSi Mantra surgical robotic system is at the core of its strategy, which aims to lower economic barriers that have traditionally limited the adoption of robotic-assisted surgery in many regions.
According to the company, more than 200 SSi Mantra systems have been installed globally, supporting over 12,000 robotic procedures across more than 170 surgical indications. This installed base reflects the system's versatility and the growing demand for minimally invasive surgery. SS Innovations continues to pursue U.S. FDA clearance and European regulatory approvals while building its international footprint.
The global surgical robotics market is evolving as healthcare systems seek technologies that improve surgical precision and expand patient access. Unlike many developers focused on premium hospital systems, SS Innovations has concentrated on reducing acquisition and operating costs, enabling more hospitals to introduce robotic-assisted procedures. The company's strategy combines world-class robotic systems, including telesurgery capabilities, with affordability and comprehensive physician training.
For more information, visit the company’s newsroom at https://ibn.fm/SSII.
This press release is distributed by InvestorWire, a specialized communications platform for press release syndication. InvestorWire is part of the Dynamic Brand Portfolio @ IBN, which delivers access to a vast network of wire solutions, article syndication to over 5,000 outlets, enhanced press release services, social media distribution, and corporate communications solutions. For more details, visit https://www.InvestorWire.com and see full terms of use and disclaimers at https://www.InvestorWire.com/Disclaimer.
